Literature DB >> 12847059

Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease.

Howard N Hodis, Wendy J Mack, Roger A Lobo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12847059     DOI： 10.1161/01.CIR.0000080080.76333.38

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

Review 1.  The assessment of non-feminizing estrogens for use in neuroprotection.

Authors:  Kun Don Yi; Evelyn Perez; Shaohua Yang; Ran Liu; Douglas F Covey; James W Simpkins
Journal:  Brain Res       Date:  2010-11-25       Impact factor: 3.252

Review 2.  Neuroprotection with non-feminizing estrogen analogues: an overlooked possible therapeutic strategy.

Authors:  James W Simpkins; Timothy E Richardson; Kun Don Yi; Evelyn Perez; Douglas F Covey
Journal:  Horm Behav       Date:  2012-04-03       Impact factor: 3.587

3.  17beta-Estradiol reverses shear-stress-mediated low density lipoprotein modifications.

Authors:  Juliana Hwang; Mahsa Rouhanizadeh; Ryan T Hamilton; Tiantian C Lin; Jason P Eiserich; Howard N Hodis; Tzung K Hsiai
Journal:  Free Radic Biol Med       Date:  2006-04-26       Impact factor: 7.376

Review 4.  Mitochondrial mechanisms of estrogen neuroprotection.

Authors:  James W Simpkins; Kun Don Yi; Shao-Hua Yang; James A Dykens
Journal:  Biochim Biophys Acta       Date:  2009-11-26

Review 5.  Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens.

Authors:  James W Simpkins; Kun Don Yi; Shao-Hua Yang
Journal:  Front Neuroendocrinol       Date:  2009-05-03       Impact factor: 8.606
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.